BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4515633)

  • 21. [Behavior of thyroid hormones in chronic hepatopathies].
    Campanini M; Saglietti G; Zaccala G; Occhipinti P; Cardano S; Monteverde A
    Recenti Prog Med; 1986 Sep; 77(9):405-10. PubMed ID: 3797791
    [No Abstract]   [Full Text] [Related]  

  • 22. [State of blood coagulation in patients with liver cirrhosis and chronic hepatitis].
    Voevidka KP
    Vrach Delo; 1974 Feb; (2):67-70. PubMed ID: 4468627
    [No Abstract]   [Full Text] [Related]  

  • 23. [Various blood platelet enzymes (LDH, G-6-PDH) in chronic hepatitis and in liver cirrhosis].
    Kiss A; Sári B; Jakó J; Zayzon R; Dán S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(2):180-90. PubMed ID: 4122961
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chronic liver diseases with normal blood protein levels].
    Buzzelli G; Gallerini L; Guarducci AM; Laffi G; Mazzanti R; Smorlesi C; Gentilini P
    Recenti Prog Med; 1977 Nov; 63(5):497-526. PubMed ID: 75556
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pathogenesis of disorder of glucose tolerance and diabetes mellitus in patients with chronic hepatitis and liver cirrhosis].
    Moskvichev AM; Shlimovich PB
    Sov Med; 1975 Sep; (9):110-4. PubMed ID: 1231013
    [No Abstract]   [Full Text] [Related]  

  • 26. Complement metabolism in chronic liver disease: catabolism of C1q in chronic active liver disease and primary biliary cirrhosis.
    Potter BJ; Elias E; Thomas HC; Sherlock S
    Gastroenterology; 1980 May; 78(5 Pt 1):1034-40. PubMed ID: 7380176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes of plasma fibrinolytic activity in chronic disorders of the liver and biliary tract].
    Pstruzinová H; Jablonská M; Richter V; Pstruzina J
    Sb Lek; 1971 Apr; 73(4):89-98. PubMed ID: 5552779
    [No Abstract]   [Full Text] [Related]  

  • 28. Importance of anticoagulant proteins in chronic liver diseases.
    Gürsoy S; Başkol M; Torun E; Yurci A; Soyuer I; Eser B; Güven K; Ozbakir O; Yücesoy M
    Turk J Gastroenterol; 2005 Sep; 16(3):129-33. PubMed ID: 16245221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifibrinolysin effect of thrombocytes.
    Schulz K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(3):263-71. PubMed ID: 4106018
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum leptin levels in patients with nonalcoholic chronic liver disease.
    Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
    Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A long-term follow-up study of the hepatic copper and serum ceruloplasmin concentrations in patients with chronic liver disease.
    Ritland S; Skrede S; Johansen O
    Scand J Gastroenterol; 1982 Jun; 17(4):545-51. PubMed ID: 7134882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunosuppressive therapy of chronic aggressive hepatitis and primary biliary cirrhosis].
    Lampe K; Hüdepohl M; Schopen RD
    Med Klin; 1972 Apr; 67(15):527-34. PubMed ID: 5053009
    [No Abstract]   [Full Text] [Related]  

  • 33. Investigations by the use of radioactive copper (64Cu) in chronic liver diseases.
    Wysocki K; Owczarek L; Górski S; Kurnatowska A
    Pol Med J; 1969; 8(1):43-9. PubMed ID: 5782169
    [No Abstract]   [Full Text] [Related]  

  • 34. [Osmotic resistance of the thrombocytes and capillary resistance in hepatocholecystitis and liver cirrhosis].
    Starodub EM
    Lab Delo; 1968; 9():535-7. PubMed ID: 4184954
    [No Abstract]   [Full Text] [Related]  

  • 35. [Serological studies on antigamma-globulin factors in liver diseases].
    Meyer zum Büschenfelde ; Hopf U; Bokisch V
    Acta Hepatosplenol; 1968; 15(2):78-88. PubMed ID: 4174702
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapy of chronic liver diseases with prednisolone and alpha-lipoic acid].
    Loginow AS
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):19-23. PubMed ID: 4925665
    [No Abstract]   [Full Text] [Related]  

  • 37. Letter: Prothrombin-complex concentrates in liver disease.
    Lancet; 1975 Jul; 2(7926):188-9. PubMed ID: 49788
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
    Shiota G; Umeki K; Okano J; Kawasaki H
    J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lecithin:cholesterol acyltransferase and plasma proteins in liver diseases.
    Blomhoff JP; Skrede S; Ritland S
    Clin Chim Acta; 1974 Jun; 53(2):197-207. PubMed ID: 4366882
    [No Abstract]   [Full Text] [Related]  

  • 40. [Protein-copper complex in primary biliary cirrhosis and other chronic diffuse diseases of the liver].
    Loginov AS; Aruin LI; Shepeleva SD
    Arkh Patol; 1980; 42(4):50-5. PubMed ID: 7396755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.